M
uch controversy surrounds the pathogenesis of acetaminopheninduced inflammation. Acetaminophen (APAP) is a well-studied xenobiotic that in high doses results in a deadly, yet preventable, form of liver failure. Although its effects are sudden and often irreversible, its mechanism is far from simple. In fact, at first glance, recent studies seem to refute each other. The field has been grappling with seemingly contradictory results driven mainly by often-generalized assumptions and different experimental systems. As always, the devil-or in this case, liver failure-is in the details. In this paper, Tang and colleagues identified macrophage-derived interleukin (IL)-1α as a mediator of sterile inflammation in a mouse model of APAP hepatotoxicity. 1 IL-1α is an alarmin 2 that unlike IL-1β, is constitutively expressed in many cells as a precursor. IL-1α precursor (pre-IL-1α) is active as a damage-associated molecular pattern (DAMP). After enzymatic cleavage, mature IL-1α can signal a more potent pro-inflammatory message.
First, to test the source of IL-1α, the authors directly probed hepatocytes, the most abundant cell type in the liver. They found that IL-1α is not derived from hepatocytes. Rather, macrophages were responsible for IL-1α production in the liver. Specifically, they found that 90% of IL-1α was derived from Kupffer cells, the resident liver macrophages (CD11b int /F4/80 high ). In an ex vivo coculture model, this secretion was dependent on MyD88, an adaptor of both TLR4 and IL-1R1. This finding suggests that MyD88 plays a role in initial sensing of hepatocyte-derived DAMPs, such as HMGB1, and in potentiating autocrine IL-1 signaling through its receptor, IL-1R.
Further probing cell-specific roles in this signaling cascade, the authors also uncovered that anti-IL-1α therapy reduced neutrophil and macrophage infiltration into the liver. Interestingly, depletion of neutrophils and monocytes had little effect on pro-inflammatory cytokines and chemokines in this model of drug-induced liver failure, suggesting their role as effector cells downstream of IL-1α release. As summarized in Figure 1 , these novel findings suggest that Kupffer cells are the source of IL-1α and that neutrophils and infiltrating macrophages are the effectors. This is supported by the requirement of MyD88 for neutrophil-sensing of necrosisinduced inflammation, 3 previously described by Ken Rock's group in 2007. Previous studies also showed that precursor IL-1α seems to preferentially target neutrophils to induce infiltration, whereas mature IL-1α recruits macrophages-highlighting the dual role of IL-1α as an alarmin and cytokine. 4 The interaction between IL-1α and neutrophils and macrophages in APAP injury has been unclear for some time. Kaplowitz and colleagues 5 showed that anti-Gr-1 antibody was effective in reducing acetaminophen-induced necrosis. Jaeschke and colleagues tried to discount neutrophil involvement by showing that anti-Gr-1 was not effective 6 -however, the authors administered Gr-1 post APAP injury, not prophylactically, as done in the original paper. A different study tested the role of neutrophils using a genetic approach-mice deficient in CD-18, 7 which is needed for leukocyte adhesion and extravasation. However, even CD-18-deficient mice had extensive hepatic neutrophils after APAP administration, which simply implies that CD-18 is dispensable, not neutrophils in general.
The authors show that IL-1α plays an important role in acetaminopheninduced liver failure, but a question that still remains is how much of this IL-1α in circulation was secreted in its mature form or passively released by Kupffer cells as a DAMP. For example, IL-1α can be cleaved by granzyme B and elastase, both present in neutrophils. Pre-IL-1α can also be cleaved by the plasma membrane-associated Ca 2+ -dependent protease, calpain, which promotes neutrophil polarization. 8 One of the strengths of this study was that the authors took careful steps to normalize all mouse strains under the same genetic background in order to avoid differences in response to acetaminophen metabolism and the ensuing inflammatory cascade driven by genotype. Moreover, they carefully titrated the lethal dose under this unified genotype at various time points. The authors then selected 48 h as an ideal time point for their work, with a dose of 600 mg/kg. This timing and dosage helped address some subtle, yet at times confounding differences from one study to another, which make it difficult to compare results across various institutions. Hopefully, the field will coalesce over a consensus in study design over this timepoint and dosage, in the same way that the field has agreed to 15-h fasting as a standard prior to APAP administration in mouse models. To achieve this goal, the authors used a variety of approaches to study the interplay between various cell types and signaling molecules. They challenged a robust repertoire of bone marrow-chimeric mice created from adoptive transfer of macrophages from mice lacking IL-1α, IL-1β, MyD88, TRIF or various TLRs (3, 4, 7/9), as well as therapeutically blocking IL-1α, IL-1β, IL-1R1, Gr-1 and Ly6G with neutralizing antibodies. Furthermore, macrophages play an important role 24 h post injury in liver regeneration, further highlighting the complexity of this signaling axis in which similar cell types can play deleterious and beneficial roles at different times. The role of NLRP3 and IL-1 signaling has been well studied in various liver diseases. 9 It is interesting that IL-1α signals through the same receptor as IL-1β, yet its phenotype is different. NLRP3 and TLR9 in liver endothelial cells have been shown to play a role in APAP liver injury. 10 However, the mechanism suggested from the current study was DNA from damaged hepatocytes acting upon macrophages. Furthermore, in addition to IL-1α as a DAMP and/or alarmin, other DAMPs such as HMGB1 have been identified in APAP drug-induced liver injury and should be further explored. Some potential caveats that should be noted about this study are that ex vivo experiments used peritoneal macrophages, not Kupffer cells. In addition, APAP studies require 15 h of starvation (which induces autophagy) for glutathione depletion and proper induction of liver injury, 11 yet IL-1α activation and secretion is inhibited by autophagy. Therefore, the true extent of IL-1α signaling may be masked by starvation in the current model. This recent study led by Tang and colleagues rich in details of timing and cell-type specificity, unravels a layer of complexity in the role of IL-1 signaling in acetaminophen-induced liver injury. Figure 1 IL-1α signaling in acetaminophen-induced liver injury. Acetaminophen overdose results in hepatocyte damage and DAMP release, which causes IL-1α release by Kupffer cells in a TLR4/MyD88-dependent manner. IL-1α then signals to neutrophils through IL-1R and its adaptor, MyD88, potentiating liver injury and the inflammatory cascade. DAMP, damage-associated molecular pattern.
